Fusion Pharmaceuticals Overview

Fusion Pharmaceuticals Research & Development

Research & Development expenses for FUSN.

Quarterly R&D Expenses

$20.95M

↑ 31.96% YoY

As of Mar 31, 2024

Annual R&D Expenses (TTM)

$74.82M

↑ 20.46% YoY

Trailing 12 months ending Mar 31, 2024

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin